Literature DB >> 21893132

The vermiform appendix and recurrent Clostridium difficile infection: a curious connection.

Xi Na, Ciáran Kelly.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21893132      PMCID： PMC5320954          DOI： 10.1016/j.cgh.2011.08.025

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  35 in total

Review 1.  Recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; C P Kelly
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

2.  Laparoscopic appendectomy in patients with refractory ulcerative colitis.

Authors:  G Järnerot; M Andersson; L Franzén
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

3.  A patient with improvement of ulcerative colitis after appendectomy.

Authors:  K Okazaki; H Onodera; N Watanabe; H Nakase; S Uose; M Matsushita; C Kawanami; M Imamura; T Chiba
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

Review 4.  Recurrent clostridium difficile.

Authors:  Seema Maroo; J Thomas Lamont
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

5.  Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

Authors:  Mary Y Hu; Kianoosh Katchar; Lorraine Kyne; Seema Maroo; Sanjeev Tummala; Valley Dreisbach; Hua Xu; Daniel A Leffler; Ciarán P Kelly
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

6.  Risk factors for early recurrent Clostridium difficile-associated diarrhea.

Authors:  A N Do; S K Fridkin; A Yechouron; S N Banerjee; G E Killgore; A M Bourgault; M Jolivet; W R Jarvis
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

Review 7.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

8.  Histological and immunological features of appendix in patients with ulcerative colitis.

Authors:  Yukihiko Jo; Takayuki Matsumoto; Shinichiro Yada; Shotaro Nakamura; Takashi Yao; Masayuki Hotokezaka; Ryuichi Mibu; Mitsuo Iida
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

9.  Treatment with monoclonal antibodies against Clostridium difficile toxins.

Authors:  Israel Lowy; Deborah C Molrine; Brett A Leav; Barbra M Blair; Roger Baxter; Dale N Gerding; Geoffrey Nichol; William D Thomas; Mark Leney; Susan Sloan; Catherine A Hay; Donna M Ambrosino
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

10.  Costs of nosocomial Clostridium difficile-associated diarrhoea.

Authors:  R-P Vonberg; C Reichardt; M Behnke; F Schwab; S Zindler; P Gastmeier
Journal:  J Hosp Infect       Date:  2008-07-07       Impact factor: 3.926
View more
  3 in total

Review 1.  The colonic microbiota and colonic disease.

Authors:  Fergus Shanahan
Journal:  Curr Gastroenterol Rep       Date:  2012-10

2.  Microbial composition of human appendices from patients following appendectomy.

Authors:  Caitriona M Guinane; Amany Tadrous; Fiona Fouhy; C Anthony Ryan; Eugene M Dempsey; Brendan Murphy; Emmet Andrews; Paul D Cotter; Catherine Stanton; R Paul Ross
Journal:  MBio       Date:  2013-01-15       Impact factor: 7.867

3.  Patients with Clostridium difficile infection and prior appendectomy may be prone to worse outcomes.

Authors:  Danial Haris Shaikh; Harish Patel; Rezwan Munshi; Haozhe Sun; Shehriyar Mehershahi; Ahmed Baiomi; Ahmed Alemam; Usman Pirzada; Iqra Nawaz; Kamrun Naher; Siddarth Hanumanthu; Suresh Nayudu
Journal:  World J Gastrointest Surg       Date:  2021-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.